Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 64Unknown 23Terminated 14Recruiting 4Active not recruiting 3Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Breast Neoplasms 12Carcinoma, Non-Small-Cell Lung 4Hodgkin Disease 3Triple Negative Breast Neoplasms 2Rhabdomyosarcoma 2Recurrence 2Neoplasms 2Advanced Breast Cancer 2Neoplasm Metastasis 1NSCLC 1Metastatic HER2-positive Breast Cancer 1Lung Neoplasms 1HER2-positive Advanced Breast Cancer 1HER2-negative Breast Cancer 1Fludzoparib" and Anti-angiogenic 1Carcinoma, Squamous Cell 1Carcinoma, Large Cell 1Adenocarcinoma 1

Interventions

pembrolizumab 117Carboplatin 104Pemetrexed 93Cisplatin 59Paclitaxel 49Drug Therapy 41osimertinib 40Nivolumab 40Docetaxel 37Specimen Handling 33Magnetic Resonance Spectroscopy 28Bevacizumab 26durvalumab 22Gemcitabine 22cemiplimab 21130-nm albumin-bound paclitaxel 21Radiotherapy 20tislelizumab 19Radiosurgery 19atezolizumab 17aflutinib 15Immunotherapy 15Cetuximab 15Platinum Compounds 13Ipilimumab 13Immune Checkpoint Inhibitors 13Biopsy 12Standard of Care 11Surgical Procedures, Operative 10Injections 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Non-Small-Cell Lung × Vinorelbine × Clear all
NCT07001618 2026-04-03

IMMUNOLIFE2

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Recruiting
162 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06908304 2026-01-12

A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC

Maia Biotechnology

Phase 3 Recruiting
300 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

NCT06908993 2025-12-17

COMET

Intergroupe Francophone de Cancerologie Thoracique

Phase 3 Recruiting
133 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05487391 2024-10-15

A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.

Qilu Pharmaceutical Co., Ltd.

Phase 3 Recruiting
632 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡